β-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial Infarction

By sjmartinez • May 22, 2024

LaFon DC, Helgeson ES, Lindberg S, Voelker H, Bhatt SP, Casaburi R, Cassady SJ, Connett J, Criner GJ, Hatipoglu U, Kaminsky DA, Kunisaki KM, Lazarus SC, McEvoy CE, Reed RM, Sciurba FC, Stringer W, Dransfield MT. β-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial Infarction. JAMA Netw Open. 2024 May 1;7(5):e247535. doi: 10.1001/jamanetworkopen.2024.7535. PMID: 38771577.

Tags: Harbor UCLA, Publications, Pulmonary, Critical Care & Sleep Medicine

Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study

Marston NA, Bergmark BA, Prohaska TA, Moura FA, Zimerman A, Alexander VJ, Kang YM, Weinland J, Ran X, Murphy SA, Zhang S, Li D, Banach[...]

Kawasaki Disease in Adults: A Call to Action to Manage Lifelong Coronary Risk

Burns JC, Budoff MJ, Gluckman TJ, Mehran R, Brindis RG, O'Gara PT, Akagi T, Bhatt J, Gordon JB, Newburger JW. Kawasaki Disease in Adults: A[...]

Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 study

Fleseriu M, Biller BMK, Webb SM, Strasburger CJ, Georgescu CE, Bidlingmaier M, Wang C, Baciu I, Casanueva FF, Gilis-Januszewska A, Hart G, Manners A, Choe[...]